Invention Grant
- Patent Title: Promiscuous HPV16-derived T helper epitopes for immunotherapy
-
Application No.: US15104165Application Date: 2014-12-01
-
Publication No.: US09932371B2Publication Date: 2018-04-03
- Inventor: Agnieszka Grabowska , Angelika Riemer
- Applicant: Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts
- Applicant Address: DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
- Current Assignee Address: DE Heidelberg
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP13196923 20131212
- International Application: PCT/EP2014/076048 WO 20141201
- International Announcement: WO2015/086354 WO 20150618
- Main IPC: C07K7/00
- IPC: C07K7/00 ; C07K9/00 ; C07K14/025 ; A61K39/12 ; A61K38/04 ; C07K14/005 ; C07K7/08 ; C12N7/00 ; A61K38/00 ; A61K39/00
Abstract:
The present invention relates to novel amino acid sequences of peptides derived from HPV16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.
Public/Granted literature
- US20160311861A1 Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy Public/Granted day:2016-10-27
Information query
